During the past decade, University of Colorado conducted 320 clinical trials. In the 10-year time frame, 320 clinical trials started and 131 clinical trials were completed, i.e. on average, 40.9% percent of trials that started reached the finish line to date. In the past 5 years, 137 clinical trials started and 77 clinical trials were completed. i.e. 56.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Colorado" #1 sponsor was "University of Colorado, Denver" with 80 trials, followed by "Hoffmann-La Roche" with 27 trials sponsored, "Bristol-Myers Squibb" with 23 trials sponsored, "Genentech, Inc." with 15 trials sponsored and "Gilead Sciences" with 15 trials sponsored. Other sponsors include 274 different institutions and companies that sponsored additional 208 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Colorado" #1 collaborator was "University of Colorado, Denver" with 17 trials as a collaborator, "National Institutes of Health (NIH)" with 11 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 9 trials as a collaborator, "University of Michigan" with 9 trials as a collaborator and "University of Pennsylvania" with 8 trials as a collaborator. Other collaborators include 337 different institutions and companies that were collaborators in the rest 239 trials.

According to Clinical.Site data, the most researched conditions in "University of Colorado" are "Melanoma" (17 trials), "Breast Cancer" (15 trials), "Colorectal Cancer" (9 trials), "Multiple Sclerosis" (9 trials) and "Parkinson's Disease" (8 trials). Many other conditions were trialed in "University of Colorado" in a lesser frequency.

Most popular intervention types in "University of Colorado" are "Drug" (255 trials), "Biological" (58 trials), "Other" (51 trials), "Device" (46 trials) and "Behavioral" (29 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (59 trials), "Nivolumab" (18 trials), "Atezolizumab" (15 trials), "Ipilimumab" (9 trials) and "Pembrolizumab" (8 trials). Other intervention names were less common.

The vast majority of trials in "University of Colorado" are 387 trials for "All" genders, 39 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are 170 active trials in "University of Colorado". 5 are not yet recruiting, 88 are recruiting, 74 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 199 completed trials in University of Colorado, undefined suspended trials, and 49 terminated clinical trials to date.

Out of the total trials that were conducted in University of Colorado, 73 "Phase 1" clinical trials were conducted, 139 "Phase 2" clinical trials and 97 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 82 trials that are defined as “Not Applicable".